• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乳腺癌进展过程中肿瘤微环境中的细胞相互作用:新前沿及其对新型治疗的意义。

Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.

机构信息

Department of Biological Sciences, College of Science and Mathematics, Auburn University, Auburn, AL, United States.

Department of Chemical Engineering, College of Engineering, Auburn University, Auburn, AL, United States.

出版信息

Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024.

DOI:10.3389/fimmu.2024.1302587
PMID:38533507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10963559/
Abstract

The breast cancer tumor microenvironment (TME) is dynamic, with various immune and non-immune cells interacting to regulate tumor progression and anti-tumor immunity. It is now evident that the cells within the TME significantly contribute to breast cancer progression and resistance to various conventional and newly developed anti-tumor therapies. Both immune and non-immune cells in the TME play critical roles in tumor onset, uncontrolled proliferation, metastasis, immune evasion, and resistance to anti-tumor therapies. Consequently, molecular and cellular components of breast TME have emerged as promising therapeutic targets for developing novel treatments. The breast TME primarily comprises cancer cells, stromal cells, vasculature, and infiltrating immune cells. Currently, numerous clinical trials targeting specific TME components of breast cancer are underway. However, the complexity of the TME and its impact on the evasion of anti-tumor immunity necessitate further research to develop novel and improved breast cancer therapies. The multifaceted nature of breast TME cells arises from their phenotypic and functional plasticity, which endows them with both pro and anti-tumor roles during tumor progression. In this review, we discuss current understanding and recent advances in the pro and anti-tumoral functions of TME cells and their implications for developing safe and effective therapies to control breast cancer progress.

摘要

乳腺癌肿瘤微环境(TME)是动态的,各种免疫和非免疫细胞相互作用,调节肿瘤的进展和抗肿瘤免疫。现在很明显,TME 中的细胞对乳腺癌的进展和对各种传统和新开发的抗肿瘤疗法的耐药性有重要贡献。TME 中的免疫和非免疫细胞在肿瘤发生、失控增殖、转移、免疫逃逸和对抗肿瘤治疗的耐药性中都起着关键作用。因此,乳腺 TME 的分子和细胞成分已成为开发新治疗方法的有前途的治疗靶点。乳腺 TME 主要由癌细胞、基质细胞、血管和浸润的免疫细胞组成。目前,针对乳腺癌特定 TME 成分的许多临床试验正在进行中。然而,TME 的复杂性及其对抗肿瘤免疫逃逸的影响需要进一步的研究,以开发新的和改进的乳腺癌治疗方法。乳腺 TME 细胞的多方面性质源于其表型和功能的可塑性,这使它们在肿瘤进展过程中具有促肿瘤和抗肿瘤的作用。在这篇综述中,我们讨论了 TME 细胞的促肿瘤和抗肿瘤功能的现有理解和最新进展,以及它们对开发安全有效的治疗方法来控制乳腺癌进展的意义。

相似文献

1
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.在乳腺癌进展过程中肿瘤微环境中的细胞相互作用:新前沿及其对新型治疗的意义。
Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024.
2
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.肿瘤微环境作为乳腺癌干性和治疗抵抗的驱动因素:新的挑战和治疗机会。
Cell Oncol (Dordr). 2021 Dec;44(6):1209-1229. doi: 10.1007/s13402-021-00634-9. Epub 2021 Sep 16.
3
Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.促甲状腺滤泡癌细胞间通讯中断可作为免疫治疗机会
Adv Exp Med Biol. 2021;1350:33-66. doi: 10.1007/978-3-030-83282-7_2.
4
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.全面剖析癌症生物学:解析肿瘤微环境,以实现肿瘤学临床的有效癌症治疗。
OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13.
5
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
6
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting.肿瘤微环境与三阴性乳腺癌的侵袭性:揭示机制与靶向治疗。
Expert Opin Ther Targets. 2022 Dec;26(12):1041-1056. doi: 10.1080/14728222.2022.2170779. Epub 2023 Jan 29.
7
Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.肿瘤微环境与一氧化氮:概念与机制。
Adv Exp Med Biol. 2020;1277:143-158. doi: 10.1007/978-3-030-50224-9_10.
8
The tumor microenvironment: shaping cancer progression and treatment response.肿瘤微环境:塑造癌症进展与治疗反应
J Chemother. 2025 Feb;37(1):15-44. doi: 10.1080/1120009X.2023.2300224. Epub 2024 Jan 5.
9
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.探讨癌症干细胞与肿瘤微环境之间的动态相互作用:对新型治疗策略的启示。
J Transl Med. 2023 Oct 2;21(1):686. doi: 10.1186/s12967-023-04575-9.
10
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.解析肿瘤微环境:洞察癌症转移和治疗策略。
Cancer Lett. 2024 Jun 1;591:216894. doi: 10.1016/j.canlet.2024.216894. Epub 2024 Apr 16.

引用本文的文献

1
Ferroptosis and non-coding RNAs in breast cancer: insights into CAF and TAM interactions.乳腺癌中的铁死亡与非编码RNA:对癌症相关成纤维细胞和肿瘤相关巨噬细胞相互作用的见解
Discov Oncol. 2025 Aug 31;16(1):1658. doi: 10.1007/s12672-025-03507-x.
2
Multimodal Phasor Approach to Study Breast Cancer Cell Invasion in a 3D Spheroid Model.多模态相量法研究三维球体模型中乳腺癌细胞的侵袭
Chem Biomed Imaging. 2025 May 15;3(7):433-442. doi: 10.1021/cbmi.5c00021. eCollection 2025 Jul 28.
3
Genetic and computational analysis of AKR1C4 gene rs17134592 polymorphism in breast cancer among the Bangladeshi population.

本文引用的文献

1
Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.癌症干细胞衍生的 CHI3L1 通过激活 MAF/CTLA4 信号通路促进三阴性乳腺癌的免疫逃逸。
J Transl Med. 2023 Oct 14;21(1):721. doi: 10.1186/s12967-023-04532-6.
2
The Role of PPARs in Breast Cancer.过氧化物酶体增殖物激活受体(PPARs)在乳腺癌中的作用。
Cells. 2022 Dec 28;12(1):130. doi: 10.3390/cells12010130.
3
Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer.
孟加拉人群乳腺癌中AKR1C4基因rs17134592多态性的遗传与计算分析
Sci Rep. 2025 Jul 28;15(1):27526. doi: 10.1038/s41598-025-13411-7.
4
N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications.N2中性粒细胞与乳腺癌的肿瘤进展:分子途径及影响
Breast Cancer (Dove Med Press). 2025 Jul 23;17:639-651. doi: 10.2147/BCTT.S542787. eCollection 2025.
5
The Autophagy Inhibitor Bafilomycin Inhibits Antibody-Dependent Natural Killer Cell-Mediated Killing of Breast Carcinoma Cells.自噬抑制剂巴弗洛霉素抑制抗体依赖性自然杀伤细胞介导的乳腺癌细胞杀伤作用。
Int J Mol Sci. 2025 Jun 28;26(13):6273. doi: 10.3390/ijms26136273.
6
The balance between N1 and N2 neutrophils implications for breast cancer immunotherapy: a narrative review.N1和N2中性粒细胞之间的平衡对乳腺癌免疫治疗的影响:一项叙述性综述。
Ann Med Surg (Lond). 2025 May 12;87(6):3682-3690. doi: 10.1097/MS9.0000000000003361. eCollection 2025 Jun.
7
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.推进乳腺癌治疗:免疫疗法和癌症疫苗在克服治疗挑战中的作用。
Vaccines (Basel). 2025 Mar 24;13(4):344. doi: 10.3390/vaccines13040344.
8
A Preliminary Study on the Therapeutic Role of γδT Cells in Triple-Negative Breast Cancer.γδT细胞在三阴性乳腺癌治疗作用中的初步研究
Kaohsiung J Med Sci. 2025 Aug;41(8):e70029. doi: 10.1002/kjm2.70029. Epub 2025 Apr 28.
9
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells.乳腺癌与肿瘤微环境:免疫细胞的关键作用
Curr Oncol. 2025 Feb 28;32(3):143. doi: 10.3390/curroncol32030143.
10
Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.氧化应激在乳腺癌发生、发展及治疗中的作用
Antioxidants (Basel). 2025 Jan 17;14(1):104. doi: 10.3390/antiox14010104.
聚焦 NK 细胞和 ADCC:HER2 阳性乳腺癌靶向治疗中一种有前景的免疫治疗方法。
Front Immunol. 2022 Dec 19;13:1083462. doi: 10.3389/fimmu.2022.1083462. eCollection 2022.
4
Tumour-infiltrating lymphocytes: from prognosis to treatment selection.肿瘤浸润淋巴细胞:从预后到治疗选择。
Br J Cancer. 2023 Feb;128(3):451-458. doi: 10.1038/s41416-022-02119-4. Epub 2022 Dec 23.
5
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.破坏NKG2A:HLA-E免疫检查点轴以增强NK细胞对癌症的激活作用。
Vaccines (Basel). 2022 Nov 23;10(12):1993. doi: 10.3390/vaccines10121993.
6
The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer.单核细胞,乳腺癌肿瘤微环境(TME)中的指挥家。
Cancers (Basel). 2022 Nov 7;14(21):5460. doi: 10.3390/cancers14215460.
7
Crosstalk between the peripheral nervous system and breast cancer influences tumor progression.外周神经系统与乳腺癌的相互作用影响肿瘤的进展。
Biochim Biophys Acta Rev Cancer. 2022 Nov;1877(6):188828. doi: 10.1016/j.bbcan.2022.188828. Epub 2022 Oct 22.
8
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights.脂肪组织与乳腺癌的相互作用:全面见解。
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188800. doi: 10.1016/j.bbcan.2022.188800. Epub 2022 Sep 11.
9
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.针对不同的癌相关成纤维细胞的靶向免疫疗法克服了难治性 HER2+ 乳腺癌肿瘤的治疗抵抗。
Nat Commun. 2022 Sep 9;13(1):5310. doi: 10.1038/s41467-022-32782-3.
10
Natural killer cell homing and trafficking in tissues and tumors: from biology to application.自然杀伤细胞在组织和肿瘤中的归巢与迁移:从生物学到应用。
Signal Transduct Target Ther. 2022 Jun 29;7(1):205. doi: 10.1038/s41392-022-01058-z.